Born in 1975, graduated from the medical school in Aarhus, Denmark in 2003. Since then clinical training and specialisation in hepatology, alongside training in clinical epidemiology. I have published more than 100 papers, most of them in the field of hepato-epidemiology. I currently do half-time clinical work, half-time research. My primary interests are alcoholic liver disease and hepatocellular carcinoma, most notably the value of surveillance for hepatocellular carcinoma among patients with alcoholic cirrhosis.

Pietro Fiocchi is a member of the European Parliament. He is also an Italian Entrepreneur and politician. After graduating in aerospace engineering at the University of Missouri of Rolla, in 1990 he entered the Navy, serving as a Sub-lieutenant on the San Giorgio landing ship until 1992 and working with the San Marco Battalion and with the Comsubin, an Italian special forces department. After two years in the navy he began his professional activity as technical director at Ravasi Robotics, an Italian robotics company, and later as manager and technical director at Fiocchi Munizioni. In 1998 he became president and member of the board of directors of Fiocchi of America. In 2007 he founded Fiocchi UK, while in 2015 he became a member of the Board of Directors of Target, a New Zealand company producing hunting and shooting cartridges. In 2019 he has been elected as a member of the European Parliament on the Brothers of Italy list. He is member of the Special Committee on Beating Cancer, of the Committee on the Environment, Public Health and Food Safety and substitute to the Committee on Industry, Research and Energy.

Frances Fitzgerald is a Fine Gael MEP for Dublin City and County. She is a member of the ECON (Economic & Monetary Affairs) Committee, FEMM (Women’s Rights & Gender Equality) Committee and DEVE (Development) Committee. Frances also serves as the lead coordinator for the European People’s Party on FEMM. Prior to her election to the European Parliament in the 2019 European Elections, Frances served as a Fine Gael Parliamentarian for over 20 years. She served as a Senator and T.D. in Dublin Mid-West (2007-2019) and has previously served as a Fine Gael T.D. in Dublin South East (1992-2002). She most recently served as Tánaiste (2016-17), one of only four women to have ever held this position. She has also served as Minister for Business, Enterprise & Innovation (2017); Minister for Justice & Equality (2014-17) and was the State’s first Minister for Children & Youth Affairs (2011-14). Frances has a clear record of delivering change and reform in Ireland stemming back to her education and early career. Raised in Stillorgan, she was educated in Dominican College Sion Hill, Blackrock and the London School of Economics. She worked as a social worker and family therapist for ten years in Ballymun Child & Family Centre and in St. Ultan’s Children’s Hospital, St. James’ Hospital and the Mater Hospital. She has also worked in inner city communities in both Dublin and London.

Prof. Frank Murray is Consultant Hepatologist/Gastroenterologist at Beaumont Hospital, Dublin and Associate Professor of Medicine at the Royal College of Surgeons in Ireland and EASL Policy and Public Health Committee Member. He graduated from University College Dublin in 1980 and trained in Dublin, Boston USA, and Nottingham, England. He was previously Consultant Gastroenterologist in Ninewells Hospital and Medical School, Dundee, Scotland. Prof. Frank Murray became a a Fellow of the Royal College of Physicians of Ireland in 1994, was elected to the Council in 2002, and was appointed Registrar in 2007. He was the 141st President of the Royal College of Physicians of Ireland from 2014-2017. Prof. Murray is also the former chair of both the Basic Specialist Training Committee and the Irish Committee on Higher Medical Training. He is a founding member of the RCPI/HSE EQUALS Initiative, a group which sources decommissioned medical equipment in Irish hospitals to send to hospitals in less developed countries and is partnering the development of Post-graduate Training in Zambia. Prof. Murray is Chairman of the RCPI Policy Group on Alcohol in 2102 , and Chairman of Alcohol Health Alliance Ireland in 2015. He has played a prominent national role in highlighting alcohol harm in Ireland and supported the introduction of evidence-based alcohol counter-measures, such as those in the Public health Alcohol Bill. Prof. Murray has recently been appointed Director, National Doctors Training and Planning (NDTP), HSE in Dublin.

Rachel Halford is CEO at The Hepatitis C Trust and part of the Board of Directors of Liver Patients International. She has over 20 years’ experience of working with people at high-risk of viral hepatitis, and liver disease generally – the homeless, prisoners, substance users and migrants. The past 15 years of which have been in senior management roles within the voluntary/ NGO sector. Passionate about equality and human rights, Rachel joined The Hepatitis C Trust in 2015 as Deputy CEO, before this she was CEO of Women in Prison, a national UK campaigning organisation that provided support and advocacy for women affected by the criminal justice system. Over the last year Rachel’s work has included working with NHS England Health and Justice setting up and delivering a Prison Peer project across the London prison estate to support the implementation of a national BBV Opt Out policy jointly developed by National Offender Management, Public Health England and NHS England. Diagnosed with Hepatitis C in 1998, Rachel completed Interferon treatment in 2007 clearing the disease.

Marko Korenjak is the president of European Liver Patients Association (ELPA) and president of Slovenian Association for patients with viral hepatitis - Slovenija HEP. He holds a Master’s degree in International Relations, a second Master’s degree in Business and Economics, and is certified as international NLP Trainer and NLP Coach. He is closely involved in the development of ELPA strategy plan, ELPA work plan and budget, ELPA fundraising activities and ELPA Symposium preparation at International Liver Congress™ organised by EASL. He works in ELPA Horizon2020 activities as project leader of dissemination and communication of the project LIVERHOPE, project MICROB-PREDICT, project GALAXY, and also in the project EIT LIVERSCREEN funded by the European Institute for Innovation and Technology – section for Health. Marko is a member of the steering committee and trainer at ELPA University was a representative of ELPA in NoHEP movement for Europe. He is a member of EASL, International Communication Association (ICA), and International NLP Trainer Association (INLPTA).

Jeffrey V. Lazarus (Ph.D., MIH, MA) is a Member of the EASL Policy and Public Health Committee. He holds positions as an associate research professor at the Barcelona Institute for Global Health (ISGlobal), Hospital Clínic, where he leads the health systems research team, as Associate Professor at the Faculty of Medicine, University of Barcelona, Spain and as a senior scholar at the CUNY Graduate School of Public Health and Policy in New York City. His decade-long career as health systems, HIV, and viral hepatitis expert at WHO Europe was followed by three years (2009-2012) as a senior specialist at the Global Fund to Fight AIDS, Tuberculosis, and Malaria, three years as director of Health Systems Global (2012-15) then board chair of the foundation AFEW International (2015-18). Prof Lazarus is now Vice-Chairman of the board of the EASL International Liver Foundation, where he developed the micro-elimination approach to HCV elimination. He is also a member of the INHSU international education committee and co-chair of the HIV Outcomes Beyond Viral Suppression coalition. He is the author of more than 300 publications and his current scientific work includes leading the Hep C Free Baleares, HBV COMSAVA, and Copenhagen T'n'T studies, and the Global COVID-19 consensus statement on ending the pandemic. He is a core member of The Lancet GastroHep Commission on Viral Hepatitis, a co-author of the Lancet COVID-19 commission and a commissioner of the EASL-Lancet European Liver Commission and The Lancet-IAPAC HIV Commission. At AME/VE he is chair of the NAFLD models of care workshop, on the organizing committee of COLDA, and on the scientific committee of IVHEM.

Dr Kremlin Wickramasinghe is acting Head of the WHO European Office for Prevention and Control of Noncommunicable Diseases (NCD Office) and Regional Adviser for Nutrition, Physical Activity and Obesity. Prior to this position, he worked as a technical officer on Noncommunicable Diseases (NCD) Risk Factors, since 2017 in the same office. Before joining WHO, he was the co-director of the WHO Collaborating Centre on Population Approaches to NCD Prevention at the University of Oxford, United Kingdom. He co-edited the text book “An Introduction to Population-level Prevention of Non-Communicable Diseases” published by the Oxford University Press. He has a special interest in multisectoral responses to health promotion, quantifying the outcome of health policies and implementation research. Kremlin graduated as a medical doctor with MBBS from the University of Colombo. He holds an MSc in Global Health Science and a DPhil (PhD) in Public Health from the University of Oxford.